RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 86 filers reported holding RELMADA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 2.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $252,840 | +21.6% | 84,280 | -0.3% | 0.00% | – |
| Q2 2023 | $207,991 | -48.6% | 84,549 | -52.8% | 0.00% | – |
| Q1 2023 | $404,440 | +38.4% | 178,956 | +113.7% | 0.00% | – |
| Q4 2022 | $292,305 | +1228.7% | 83,755 | +13766.7% | 0.00% | – |
| Q3 2022 | $22,000 | +450.0% | 604 | +177.1% | 0.00% | – |
| Q2 2022 | $4,000 | -33.3% | 218 | -6.4% | 0.00% | – |
| Q1 2022 | $6,000 | – | 233 | +1065.0% | 0.00% | – |
| Q4 2021 | $0 | – | 20 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,270,072 | $61,269,000 | 9.93% |
| GREAT POINT PARTNERS LLC | 790,000 | $21,322,000 | 5.15% |
| ACUTA CAPITAL PARTNERS, LLC | 342,000 | $9,231,000 | 4.31% |
| COWEN AND COMPANY, LLC | 1,164,361 | $31,426,000 | 3.02% |
| Altium Capital Management LP | 206,000 | $5,560,000 | 1.86% |
| BVF INC/IL | 1,647,400 | $44,463,000 | 1.78% |
| RTW INVESTMENTS, LP | 2,540,074 | $68,557,000 | 1.42% |
| Vivo Capital, LLC | 705,882 | $19,052,000 | 1.31% |
| RA Capital Management | 2,000,000 | $53,980,000 | 1.18% |
| SPHERA FUNDS MANAGEMENT LTD. | 291,252 | $7,861,000 | 1.11% |